// App-Quantinova.ai

: Real-World Data Analysis of the Molecular Response Kinetics within the Two First Years of the RELMC-NOVA Study in Newly Diagnosed Spanish CML-CP Patients Treated with Tirosin Kinasa Inhibitors (TKIs) in First Line

Researchers

Presenter

  • Luis Felipe Casado Montero

Principal Investigators

  • Manuel Perez Encinas

  • Santiago Osorio-Prendes

  • Francisca Ferrer Marin

  • Miguel Sagues

  • Valentin Garcia-Gutierrez

  • Fernando Marco De Lucas

  • Concepcion Boque

  • Soledad Noya

  • Maria Teresa Gomez Casares

  • Natalia Estrada

  • Maria Angeles Goñi

  • Angel Ramirez Payer

  • Maria Jose Requena

  • Sunil Lakhwani

  • Marcio Miguel Andrade Campos

  • Natalia de las Heras

  • Maria Angeles Foncillas

  • Juan Luis Steegmann

Medical Centers

  • Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain

  • La Princesa University Hospital, MADRID, Spain

  • Severo Ochoa Hospital, Madrid, Spain

  • Josep Carreras Leukemia Research Institute. Institut Català d'Oncologia (ICO)-Hospital Germans Trias i Pujol, Barcelona, Spain

  • Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain

  • Infanta Leonor Universitary Hospital, Madrid, Spain

  • University Hospital of the Canary Islands, Santa Cruz de Tenerife, Spain

  • Morales Meseguer Hospital, IMIB, CIBERER, UCAM, Murcia, Spain

  • ICO Bellvitge H. Durán i Reynals, Barcelona, Spain

  • University Hospital Complex A Coruña, A Coruña, Spain

  • Complejo Hospitalario de Navarra, Navarra, Spain

  • Ramon y Cajal University Hospital, Madrid, Spain

  • Hospital Del Mar, Barcelona, Spain

  • HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARANON, MADRID, Spain

  • ICO Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain

  • Basurto University Hospital, Bizkaia, ESP

  • Complejo Asistencial Universitario de Leon, Leon, Spain

  • Hospital General Universitario de Toledo, Toledo, Spain

  • Central University Hospital of asturias, asturias, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved